Search results for "VIRUS"

showing 10 items of 5024 documents

Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.

1990

In a multicentre trial, 82 patients known to be hepatitis B e antigen and hepatitis B virus DNA positive for at least 1 year, with elevated serum alanine aminotransferase levels and chronic liver lesions on biopsy, were randomized to receive either recombinant interferon alfa-2a at a dose of 4.5 million units thrice weekly for 4 months or no treatment. At the end of therapy, viral DNA clearance and aminotransferase normalization were significantly (p less than 0.05) more frequent in treated patients than in controls. After 16 months' follow up, the difference was still significant for hepatitis B e antigen clearance and transaminase normalization. Hepatitis B virus DNA reactivation was obse…

AdultMaleAlpha interferonInterferon alpha-2medicine.disease_causeTransaminaseLiver diseaseInterferonBiopsymedicineHumanschronic hepatitis BHepatitis B e AntigensHepatitis B virustherapyHepatitis B Surface AntigensHepatologybiologymedicine.diagnostic_testbusiness.industryInterferon-alphaAlanine TransaminaseinterferonHepatitis Bmedicine.diseaseHepatitis BRecombinant ProteinsAlanine transaminaseLiverImmunologyChronic Diseasebiology.proteinFemalechronic hepatitis B; therapy; interferonbusinessBiomarkersmedicine.drugFollow-Up StudiesJournal of hepatology
researchProduct

Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.

1990

The pattern of free and antibody-complexed HIV antigen and the antibody profile were investigated retrospectively in 305 serum samples taken from 22 AIDS patients before and during the development of AIDS and from 40 apparently healthy seropositive individuals. Most AIDS patients were found positive for both free and complexed antigen and had high gp41 antibody titres but low or undetectable p24 antibody. Four different patterns of HIV antigenaemia were observed: 1) positive for both free and complexed antigen; 2) negative for free HIV antigen at first, but always positive for complexed antigen; 3) positive for free antigen without complexed antigen; and 4) negative for both free and comple…

AdultMaleAntigen-Antibody ComplexHIV AntigensHIV Core Protein p24Gene Products gagAntigen-Antibody ComplexBiologyHIV AntibodiesVirusImmune systemAcquired immunodeficiency syndrome (AIDS)AntigenHIV SeroprevalenceVirologyHIV SeropositivitymedicineHumansSubstance Abuse IntravenousAcquired Immunodeficiency SyndromeViral Core Proteinsmedicine.diseaseVirologyImmune complexHIV Envelope Protein gp41Infectious DiseasesItalyImmunologybiology.proteinFemaleViral diseaseAntibodyBiomarkersJournal of medical virology
researchProduct

Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors

2002

Abstract Background. Infection with transfusion transmitted virus, a new member of the Parvoviridae family, has been found in patients both with chronic and fulminant post-transfusion cryptogenic hepatitis. Aim. To evaluate the prevalence and clinical impact of transfusion transmitted virus infection in Italy. Patients and Methods. Studies were carried out on 256 patients and control subjects from three centres from Northern, Central and Southern Italy (92 nonA-nonC chronic hepatitis, 10 acute non fulminant cryptogenic hepatitis, 41 hepatitis C virus-related chronic hepatitis and 113 blood donors). Serum transfusion transmitted virus was detected by nested polymerase chain reaction using tw…

AdultMaleBlood transfusionAdolescentmedicine.medical_treatmentHepatitis C virusBlood Donorsblood transfusionmedicine.disease_causeVirusTransfusion transmitted virusLiver diseasetransfusion transmitted virusmedicinePrevalenceHumansAgedHepatitis ChronicHepatitis B virusHepatitisTorque teno virusblood transfusion; cryptogenic chronic liver disease; transfusion transmitted virusHepatologybiologybusiness.industryGastroenterologyHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationVirologyDNA Virus InfectionsItalyImmunologyDNA ViralFemalebusinesscryptogenic chronic liver disease
researchProduct

Herpes Simplex I virus impairs regenerative outcomes of periodontal regenerative therapy in intrabony defects: a pilot study.

2011

Aim To evaluate the impact of herpesvirus type-1 and -2 on the clinical outcomes of periodontal regenerative procedures in isolated deep intrabony pockets, in an experimental population with no detectable periodontal pathogens. Materials and Methods Seventeen periodontal intraosseous defects in 17 moderate-to-advanced periodontitis patients were treated with regenerative therapy and amelogenins. Microbiological evaluation was performed at baseline (after the completion of initial therapy) and at 1 year to exclude the presence of periodontal pathogens. Herpesviruses-1 and -2 DNA were quantified in the pocket tissues associated to the intrabony defect using molecular assays. Clinical attachme…

AdultMaleBone RegenerationCONTROLLED CLINICAL-TRIALHerpesvirus 2 HumanHEALING RESPONSEPopulationAlveolar Bone LossDentistryHerpesvirus 1 HumanACCESS FLAPStatistics NonparametricYoung AdultDental Enamel ProteinsEnamel matrix derivativemedicineAggressive periodontitisHumansPeriodontal PocketGingival RecessionYoung adulteducationBone regenerationGingival recessionGUIDED TISSUE REGENERATIONBONY DEFECTSPeriodontitiseducation.field_of_studybusiness.industryAGGRESSIVE PERIODONTITISMiddle Agedmedicine.diseaseMICROBIOTAHUMAN HERPESVIRUSESPREVALENCEGUIDED TISSUE REGENERATION MINIMALLY INVASIVE SURGICAL TECHNIQUE CONTROLLED CLINICAL-TRIAL AGGRESSIVE PERIODONTITIS HUMAN HERPESVIRUSES HEALING RESPONSE BONY DEFECTS ACCESS FLAP PREVALENCE MICROBIOTAReal-time polymerase chain reactionTreatment OutcomeChronic PeriodontitisDNA ViralGuided Tissue Regeneration PeriodontalPeriodonticsFemaleMINIMALLY INVASIVE SURGICAL TECHNIQUEmedicine.symptombusinessJournal of clinical periodontology
researchProduct

The association between depression symptoms, psychological burden caused by Covid-19 and physical activity: An investigation in Germany, Italy, Russi…

2020

Highlights • Depression symptoms are positively linked to burden by Covid-19. • Physical activity can buffer the impact of depression on the burden experience. • Physical activity is a protective factor against negative Covid-19 consequences. • Same result pattern in Germany, Italy, Russia and Spain.

AdultMaleBurden by covid-19Coronavirus disease 2019 (COVID-19)PopulationPhysical activityArticleRussia03 medical and health sciences0302 clinical medicineGermanyEnvironmental healthHumansMedicineAssociation (psychology)educationEveryday lifeExerciseDepression (differential diagnoses)Biological Psychiatryeducation.field_of_studyDepressionPhysical activitybusiness.industryCOVID-19OutbreakPhysical health030227 psychiatryPsychiatry and Mental healthItalySpainFemalebusinessStress Psychological030217 neurology & neurosurgeryPsychiatry Research
researchProduct

D2-40 negative pyogenic granuloma-like Kaposi's sarcoma: Diagnostic features and histogenetic hypothesis of an uncommon skin tumor in HIV-negative pa…

2015

Locate full-text(opens in a new window)|View at Publisher| Export | Download | Add to List | More... Pathology Research and Practice Volume 211, Issue 7, July 01, 2015, Pages 528-532 D2-40 negative pyogenic granuloma-like Kaposi's sarcoma: Diagnostic features and histogenetic hypothesis of an uncommon skin tumor in HIV-negative patients (Article) Cabibi, D.a, Giannone, A.G.a , Guarnotta, C.a, Schillaci, O.b, Franco, V.a a Department of Sciences for Promotion of Health and Mother and Child Care, University of Palermo, Palermo, Italy b Servizio di Anatomia Patologica, Dipartimento Oncologico di III livello, La Maddalena Casa di Cura di Alta Specialità, Palermo, Italy View references (20) Abst…

AdultMaleCD31Pathologymedicine.medical_specialtySkin NeoplasmsCD34Pyogenic granuloma-like Kaposi's sarcomaSettore MED/08 - Anatomia PatologicaVascular tumorPathology and Forensic MedicineD2-40Antibodies Monoclonal Murine-DerivedBiomarkers TumormedicineHHV8HumansGranuloma PyogenicSarcoma KaposiKaposi's sarcomaSkinRetrospective StudiesPodoplaninPyogenic granulomabusiness.industryKaposi's sarcomaCell BiologyMiddle Agedmedicine.diseaseImmunohistochemistryPyogenic granulomaLymphatic systemHerpesvirus 8 HumanFemaleSarcomaDifferential diagnosisbusinessImmunostainingPathology - Research and Practice
researchProduct

Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents.

2022

Immunosenescence may impact the functionality and breadth of vaccine-elicited humoral immune responses. The ability of sera to neutralize the SARS-CoV-2 spike protein (S) from Beta, Gamma, Delta, and Epsilon variants of concern (VOCs) relative to the ancestral Wuhan-Hu-1 strain was compared in Comirnaty COVID-19-vaccinated elderly nursing home residents, either SARS-CoV-2 naïve (n = 22) or experienced (n = 8), or SARS-CoV-2 naïve younger individuals (n = 18) and non-vaccinated individuals who recovered from severe COVID-19 (n = 19). In all groups, except that including SARS-CoV-2-experienced nursing home residents, some participants lacked NtAb against one or more VOCs, mainly the Beta vari…

AdultMaleCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibodies ViralImmune systemProtein DomainsNeutralization TestsMedicineHumansBeta (finance)AgedRetrospective StudiesAged 80 and overMultidisciplinarybiologybusiness.industrySARS-CoV-2COVID-19ImmunosenescenceMiddle AgedAntibodies NeutralizingFold changeImmunity HumoralNursing HomesTiterImmunologySpike Glycoprotein Coronavirusbiology.proteinFemaleAntibodybusinessScientific reports
researchProduct

Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic.

1998

Sera from 450 individuals between the age of 1 and 80 years, representing the general population of the Czech Republic, were tested for the presence of antibodies to human-papillomavirus(HPV)-derived antigens. The following antigens were used: (i) HPV1 virions; (ii) HPV16, -18 and -33-virus-like particles (VLP); (iii) peptides derived from L2 open reading frames (ORFs) of HPV16 and HPV6/11; (iv) peptides derived from HPV16 E2, E4 and E7 ORFs of HPV16. The prevalence of antibodies reactive with the capsid-derived antigens was age-dependent, while no clear age dependence was observed in the distribution of antibodies to peptides derived from HPV16 early proteins. In individual sera, high corr…

AdultMaleCancer ResearchAdolescentvirusesPopulationUterine Cervical NeoplasmsIn Vitro TechniquesAntibodies ViralVirusSerologyOpen Reading FramesAntigenReference ValuesMedicineHumansORFSeducationChildAntigens ViralPapillomaviridaeAgedCzech Republiceducation.field_of_studybiologybusiness.industryAge Factorsvirus diseasesInfantMiddle AgedVirologyOpen reading frameOncologyChild PreschoolImmunologybiology.proteinFemaleViral diseaseAntibodybusinessInternational journal of cancer
researchProduct

Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study.

2011

Background: Kaposi's sarcoma-associated herpes virus is associated with primary effusion lymphoma and multicentric Castleman's disease. Methods: Seropositivity to lytic and latent Kaposi's sarcoma herpes virus (KSHV) antigens were examined in 2083 lymphomas and 2013 controls from six European countries. Results: Antibodies against KSHV latent and lytic antigens were detectable in 4.5% and 3.4% of controls, respectively, and 3.6% of cases (P>0.05). The KSHV seropositivity was associated with splenic marginal zone lymphoma (SMZL) (odds ratio (OR)=4.11, 95% confidence interval (CI)=1.57–10.83) and multiple myeloma (OR=0.31, 95% CI=0.11–0.85). Conclusion: The KSHV is unlikely to contribute impo…

AdultMaleCancer ResearchAdolescentvirusesShort CommunicationserologylymphomaAntibodiesSerologyhuman herpes virus 8Young AdultHerpes virusAntigenhemic and lymphatic diseasesLymphoma Primary EffusionmedicineHumansChildKaposi's sarcomaAntigens ViralSarcoma KaposiAgedAged 80 and overbiologybusiness.industryCastleman DiseaseLymphoma Non-HodgkinCase-control studyInfant Newbornvirus diseasesInfantMiddle Agedmedicine.diseaseVirologyLymphomaEuropeOncologyLytic cycleKaposi's sarcoma-associated herpes virusCase-Control StudiesChild PreschoolImmunologyHerpesvirus 8 Humanbiology.proteinFemaleepidemiologyAntibodybusinessBritish journal of cancer
researchProduct

Effect of antiviral treatment and host susceptibility on positive selection in hepatitis C virus (HCV).

2007

Abstract We have conducted a large sequence study of the E1–E2 and NS5A regions of the HCV, subtypes 1a and b, both in patients previously treated with interferon, and untreated patients, who later responded, or not, to a combination therapy based on interferon plus ribavirin. We have examined the role played by the number of positively selected sites on disease progression and its relationship with several variables such as patients’ age, sex and their risk of acquiring the disease. We have detected three groups of patients that respond or not to combination therapy: responders of intermediate age, older non-responders and young non-responders, they possess an increasing average number of …

AdultMaleCancer ResearchCombination therapyHepatitis C virusMolecular Sequence DataDiseaseHepacivirusBiologyViral Nonstructural Proteinsmedicine.disease_causeAntiviral Agentschemistry.chemical_compoundViral Envelope ProteinsInterferonVirologyRibavirinmedicineHumansAmino Acid SequenceSelection GeneticNS5AAgedHost (biology)Positive selectionRibavirinSequence Analysis DNAMiddle AgedHepatitis CInfectious DiseasesTreatment OutcomechemistryAmino Acid SubstitutionImmunologyRNA ViralFemaleInterferonsmedicine.drugVirus research
researchProduct